Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Cirrhosis

Free Subscription 01.07.2024 1 Dig Dis Sci 2 Gastroenterology 1 Hepatology 1 Intern Med 5 J Hepatol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Dig Dis Sci

1. BROWN C, Hernandez R, Ford T, Aksan N, et al
   Inadequate Dietary Education and Poor Adherence to a High Protein, Low Sodium Diet in Cirrhosis: Mixed Methods Approach.
   Dig Dis Sci. 2024 Jun 28. doi: 10.1007/s10620-024-08526.
   PubMed         Abstract available
   
   

   
   Gastroenterology

2. VENKATESWARAN N
   Seladelpar as an alternate second line agent for Primary Biliary Cirrhosis.
   Gastroenterology. 2024 Jun 20:S0016-5085(24)05064.
   PubMed        
   
   
3. VAN KLEEF LA, Francque SM, Prieto-Ortiz JE, Sonneveld MJ, et al
   Metabolic Dysfunction-Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction.
   Gastroenterology. 2024;167:357-367.
   PubMed         Abstract available
   
   

   
   Hepatology

4. KANG K, Wu Y
   Letter to the Editor: Regarding the use of decision curve analysis in predicting long-term complications of liver cirrhosis.
   Hepatology. 2024 Jun 21. doi: 10.1097/HEP.0000000000000945.
   PubMed        
   
   

   
   Intern Med

5. SUEKI A, Kaya D, Nagamatsu S, Yamamoto C, et al
   A Case of Secondary Growth Hormone Deficiency that Developed into Cirrhosis after Several Years of Interrupted Growth Hormone Replacement Therapy.
   Intern Med. 2024 Jun 27. doi: 10.2169/internalmedicine.3896.
   PubMed         Abstract available
   
   

   
   J Hepatol

6. ROONEY M, Duduskar SN, Ghait M, Reissing J, et al
   Type-I interferon shapes peritoneal immunity in cirrhosis and drives caspase-5-mediated progranulin release upon infection.
   J Hepatol. 2024 Jun 25:S0168-8278(24)02325-0. doi: 10.1016/j.jhep.2024.
   PubMed         Abstract available
   
   
7. MCGETTIGAN B, Shah V
   EVERY SHERIFF NEEDS A DEPUTY: TARGETING NON-PARENCHYMAL CELLS TO TREAT HEPATIC FIBROSIS.
   J Hepatol. 2024 Apr 25:S0168-8278(24)00283-6. doi: 10.1016/j.jhep.2024.
   PubMed        
   
   
8. SEMMLER G, Alonso Lopez S, Pons M, Lens S, et al
   Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure.
   J Hepatol. 2024 Mar 21:S0168-8278(24)00198-3. doi: 10.1016/j.jhep.2024.
   PubMed         Abstract available
   
   
9. HE S, Luo Y, Ma W, Wang X, et al
   Endothelial POFUT1 controls injury-induced liver fibrosis by repressing fibrinogen synthesis.
   J Hepatol. 2024;81:135-148.
   PubMed         Abstract available
   
   
10. FAN X, Yang F, Zhou L, Yang L, et al
    Mycophenolate mofetil for the induction of remission in primary biliary cholangitis with predominant features of autoimmune hepatitis.
    J Hepatol. 2024 Jan 31:S0168-8278(24)00097-7. doi: 10.1016/j.jhep.2024.
    PubMed        
    
    

    
    PLoS One

11. NAM DE, Park SJ, Omole S, Um E, et al
    Activated Gab1 drives hepatocyte proliferation and anti-apoptosis in liver fibrosis via potential involvement of the HGF/c-Met signaling axis.
    PLoS One. 2024;19:e0306345.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.